
A federal judge on Monday nullified patents associated with human genes known to detect early signs of breast and ovarian cancer.
It was the first time a federal court has invalidated a patent on genes. The American Civil Liberties Union, which brought the case, said the New York federal court decision “calls into question the validity of patents now held on approximately 2,000 genes.”
U.S. District Judge Robert Sweet agreed with the civil rights group that the patents were invalid because they covered the most basic element of every person’s individuality. “Products of nature do not constitute patentable subject matter absent a change that results in the creation of a fundamentally new product,” Sweet wrote in a 152-page opinion.
The lawsuit claimed the patents were so broad they barred scientists from examining and comparing the BRCA1 and BRCA2 genes at the center of the dispute. The patents issued more than a decade ago covered any new scientific methods of looking at these human genes that might be developed by others.

Google has been aggressively expanding its Book Search program to include non-English library materials. It recently announced a deal with the University of Lausanne to scan a large collection of French-language works, and the new partnership with Mysore will digitize works in Sanskrit and Kannada. These schools lack the fear of Google displayed by the French government, which has so far introduced projects like Gallica and Quaero to challenge the search giant without any apparent success.
Internet censorship is growing worldwide, with 26 out of 40 countries blocking or filtering political or social content, a study reported Friday.